Eli Lilly and Company 13D and 13G filings for Sigilon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:33 pm Purchase |
2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
1,008,830 40.300% |
797,719 (+377.87%) |
Filing |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
211,111 8.800% |
211,111 (New Position) |
Filing |